Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
Condition(s):Leishmaniasis, CutaneousLast Updated:June 2, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Leishmaniasis, CutaneousLast Updated:June 2, 2010Completed
Condition(s):Cutaneous LeishmaniasisLast Updated:August 16, 2011Unknown status
Condition(s):Cutaneous LeishmaniasisLast Updated:January 25, 2017Completed
Condition(s):Leishmaniasis; Effects of ImmunotherapyLast Updated:August 28, 2013Withdrawn
Condition(s):Cutaneous LeishmaniasisLast Updated:July 26, 2016Completed
Condition(s):Leishmaniasis, MucocutaneousLast Updated:February 15, 2007Completed
Condition(s):Visceral LeishmaniasisLast Updated:April 3, 2009Completed
Condition(s):Leishmaniasis, CutaneousLast Updated:February 15, 2007Completed
Condition(s):Leishmaniasis; Leishmaniasis, MucocutaneousLast Updated:June 9, 2015Completed
Condition(s):Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis; AmericanLast Updated:September 26, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.